Soluble Guanylate Cyclase-α1 Deficiency Selectively Inhibits the Pulmonary Vasodilator Response to Nitric Oxide and Increases the Pulmonary Vascular Remodeling Response to Chronic Hypoxia
Pieter Vermeersch(Universitair Ziekenhuis Leuven), Stefan Janssens(Maastricht University), Amanda Graveline(Harvard University), Mieke Dewerchin(Vlaams Instituut voor Biotechnologie), Glenn Marsboom(Johnson & Johnson (United States)), Fumito Ichinose(Harvard University), Marc Swinnen(Ghent University), Patrick Sips(Ghent University Hospital), Peter Brouckaert(Vlaams Instituut voor Biotechnologie), Emmanuel S. Buys(Harvard University), Marijke Pellens(Ghent University), Kenneth D. Bloch(Harvard University), Péter Pokreisz(Ghent University), Désiré Collen(Ghent University), Hilde Gillijns(Ghent University)
Cited by 68
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Inhaled Nitric Oxide
|Circulation|2004|533